FORMATO, Marilena
 Distribuzione geografica
Continente #
NA - Nord America 7.317
AS - Asia 4.385
SA - Sud America 2.831
EU - Europa 2.663
AF - Africa 157
Continente sconosciuto - Info sul continente non disponibili 23
OC - Oceania 18
Totale 17.394
Nazione #
US - Stati Uniti d'America 7.158
BR - Brasile 2.556
SG - Singapore 1.773
CN - Cina 1.559
UA - Ucraina 1.119
HK - Hong Kong 407
DE - Germania 396
IT - Italia 342
FI - Finlandia 191
SE - Svezia 181
VN - Vietnam 132
GB - Regno Unito 124
AR - Argentina 102
FR - Francia 87
TR - Turchia 80
CA - Canada 65
IQ - Iraq 61
ZA - Sudafrica 53
IN - India 47
EC - Ecuador 45
MX - Messico 45
RU - Federazione Russa 44
BD - Bangladesh 43
VE - Venezuela 42
UZ - Uzbekistan 39
KR - Corea 38
PK - Pakistan 36
BE - Belgio 33
MA - Marocco 31
PL - Polonia 23
CO - Colombia 21
JP - Giappone 20
PE - Perù 20
NP - Nepal 18
AU - Australia 17
EU - Europa 17
NL - Olanda 17
TN - Tunisia 17
AE - Emirati Arabi Uniti 16
ES - Italia 16
KE - Kenya 15
PY - Paraguay 15
ID - Indonesia 14
CL - Cile 12
UY - Uruguay 12
DZ - Algeria 11
AZ - Azerbaigian 10
EG - Egitto 10
GR - Grecia 10
JM - Giamaica 10
JO - Giordania 10
KG - Kirghizistan 10
KZ - Kazakistan 10
CZ - Repubblica Ceca 9
LB - Libano 9
AT - Austria 8
DO - Repubblica Dominicana 8
AL - Albania 7
DK - Danimarca 7
BG - Bulgaria 6
BO - Bolivia 6
CR - Costa Rica 6
HN - Honduras 6
IL - Israele 6
LT - Lituania 6
OM - Oman 6
PS - Palestinian Territory 6
BA - Bosnia-Erzegovina 5
HR - Croazia 5
AM - Armenia 4
AO - Angola 4
CI - Costa d'Avorio 4
GE - Georgia 4
GT - Guatemala 4
NI - Nicaragua 4
SN - Senegal 4
XK - ???statistics.table.value.countryCode.XK??? 4
CG - Congo 3
CH - Svizzera 3
IE - Irlanda 3
IR - Iran 3
LU - Lussemburgo 3
PA - Panama 3
PH - Filippine 3
RO - Romania 3
RS - Serbia 3
SA - Arabia Saudita 3
A2 - ???statistics.table.value.countryCode.A2??? 2
BH - Bahrain 2
BN - Brunei Darussalam 2
BY - Bielorussia 2
KW - Kuwait 2
MD - Moldavia 2
MK - Macedonia 2
MY - Malesia 2
NO - Norvegia 2
QA - Qatar 2
TH - Thailandia 2
TT - Trinidad e Tobago 2
BS - Bahamas 1
Totale 17.373
Città #
Dallas 2.491
Chandler 1.028
Singapore 918
Jacksonville 684
Hong Kong 407
Princeton 356
Beijing 297
Nanjing 294
Ashburn 211
New York 207
São Paulo 205
Dearborn 172
Wilmington 147
Sassari 142
Nanchang 134
Shanghai 107
Ann Arbor 102
Boardman 98
Shenyang 85
Los Angeles 83
Rio de Janeiro 78
Hebei 71
Tianjin 71
Changsha 68
Belo Horizonte 66
Santa Clara 60
Ho Chi Minh City 48
Jiaxing 47
Woodbridge 45
Campinas 41
Curitiba 40
Andover 39
Buffalo 39
Jinan 39
Seoul 38
Zhengzhou 37
Tashkent 36
Ningbo 34
Porto Alegre 34
San Francisco 34
Brussels 33
Brasília 32
Johannesburg 31
Kunming 31
Mountain View 31
Izmir 28
Hangzhou 27
Toronto 27
Baghdad 25
Salvador 25
Norwalk 24
Hanoi 23
Warsaw 23
Guarulhos 22
Guangzhou 21
Ribeirão Preto 21
Brooklyn 19
Fortaleza 19
Goiânia 19
London 19
Tokyo 19
Manaus 18
Montreal 18
Orem 18
Sorocaba 18
Santo André 17
Cagliari 16
Campo Grande 16
Guayaquil 16
Helsinki 16
Juiz de Fora 16
Osasco 16
Quito 15
São José dos Campos 15
Taizhou 15
Denver 14
Lima 14
Mauá 14
Nairobi 14
Recife 14
São Gonçalo 14
Ankara 13
Bragança Paulista 13
Casablanca 13
Chennai 13
Dhaka 13
Mumbai 13
Phoenix 13
Stockholm 13
Aracaju 12
Atlanta 12
Bauru 12
Betim 12
Boston 12
Istanbul 12
São Bernardo do Campo 12
Villiers-sur-marne 12
Caracas 11
Caxias do Sul 11
Contagem 11
Totale 10.199
Nome #
A novel LIF-CE method for the separation of hyaluronan- and chondroitin sulfate-derived disaccharides: Application to structural and quantitative analyses of human plasma low- and high-charged chondroitin sulfate isomers 203
A proteomic approach to differentiate histologically classified stable and unstable plaques from human carotid arteries. IF 2009: 4.522 JCR: Q1 180
Albumin-bound low molecular weight thiols analysis in plasma and carotid plaques by CE 179
A poly-L-lactic acid/ collagen/glycosaminoglycan matrix for tissue engineering applications 170
A study of the switch of fetal hemoglobin in newborn erythrocytes fractionated by density gradient 167
Assessment of protein-incorporated arginine methylation in biological specimens by CZE UV-detection 164
Apolipoprotein Profiles in Atherosclerotic Disease 160
Natural collagenic skeleton of marine sponges in pharmaceutics: Innovative biomaterial for topical drug delivery 156
Apolipoprotein profiles in atherosclerotic disease 152
A study of the switch of fetal hemoglobin in newborn erytrocytes fractionated by density gradient. 150
Identification of differentially expressed plasma proteins in atherosclerotic patients with type 2 diabetes 149
A reversed phase HPLC method for the simultaneous determination of all monosaccharides contained in galactosaminoglycan isomers from human aorta proteoglycans 147
Association between human plasma chondroitin sulphate isomers and carotid atherosclerotic plaque 144
Applications of two-dimensional electrophoresis technology to the study of atherosclerosis 144
Biodiversità marina della Sardegna: prospettive di valorizzazione e sfruttamento sostenibile dei poriferi 143
Molecular Characterization of Plasma HDL, LDL, and VLDL Lipids Cargos from Atherosclerotic Patients with Advanced Carotid Lesions: A Preliminary Report 142
Kidney post-transplant monitoring of urinary glycosaminoglycans/proteoglycans and monokine induced by IFN-g (MIG) 139
Evaluation of Early Markers of Nephropathy in Patients with Type 2 Diabetes Mellitus 137
Apolipoprotein Profiles in Atherosclerotic Disease 136
Content and distribution of glycosaminoglycans/proteoglycans in human thoracic aortic aneurysm 136
Human serum albumin Cys34 oxidative modifications following infiltration in the carotid atherosclerotic plaque 135
Morfogenesi cronica dei poriferi: la strutturazione della matrice extracellulare è modulata dai glicosaminoglicani? 134
Differential proteomic analysis of human atherosclerotic plaque extracts 133
Additive effects of Simvastatin beyond its effects on LDL cholesterol in hypertensive type 2 diabetic patients. IF 2000: 2.071 JCR: Q1 131
Short-end injection capillary electrophoresis for quantification of plasma chondroitin sulfate isomer disaccharides 128
Apolipoprotein profiles in atherosclerotic disease 125
Polymorphism of foetal haemoglobin in the sardinian Beta+-Thalassaemia. 124
A Method for Urinary Trypsin Inhibitor (UTI) Purification Combining Anion-Exchange Chromatography Enrichment and Preparative SDS-PAGE 123
DNA polymorphisms in north-Sardinian newborns and their linkage with abnormal gamma globin gene arrangements and with B°-thalassemia 123
Adhesion properties and proteoglycans produced by subsequent subcultures of rat fibroblasts with different contact inhibition 122
Evaluation of human serum albumin sulfhydryl groups oxidation in plasma and atherosclerotic plaque extracts 120
Buoyant density of Lp(a) subclasses in hypercholesterolemia 120
Distribution of low - density lipoprotein-bound low molecular weight thiols: a new analytical approach 120
Glycosaminoglycan and transforming growth factor beta 1 changes in human plasma and urine during the menstrual cycle, in vitro fertilization treatment, and pregnancy 120
IDENTIFICATION OF POTENTIAL BIOMARKERS IN MYASTHENIA GRAVIS DISEASE BY PLASMA PROTEOMIC ANALYSIS 119
Dna polymorphisms in north sardinian newborns and their linkage with abnormal globin gene arrangiements and with beta°-thalassemia 118
Evaluation of plasma glycosaminoglycans levels and structure in patients undergoing carotid endarterectomy 118
Differential distribution of structural components and hydration in aortic and pulmonary heart valve conduits: Impact of detergent-based cell removal. IF 2010: 4.824 JCR: Q1 118
A proteomic approach to identify circulating or tissue biomarkers of atherosclerosis 117
Development of a method for urine bikunin/urinary trypsin inhibitor (UTI) quantitation and structural characterization: Application to type 1 and type 2 diabetes 116
Levels of Urinary Trypsin Inhibitor and Structure of Its Chondroitin Sulphate Moiety in Type 1 and Type 2 Diabetes 115
Glycosaminoglycan functionalization of electrospun scaffolds enhances Schwann cell activity 115
Kidney post-transplant monitoring of urinary glycosaminoglycans/proteoglycans and monokine induced by IFN-γ (MIG). 115
Impact of first trimester fasting glycemic levels on expression of proteoglycans in pregnancy 113
Evaluation of human serum albumin sulfhydryl groups oxidation in plasma and atherosclerotic plaque extracts 112
Diagnosi neonatale delle emoglobinopatie mediante isoelettrofocusing delle Emoglobine 112
Polymorphism of foetal haemoglobin in the Sardinian B+-thalassemia 110
Characterization of glycosaminoglycans in human plasma from patients receiving haemodyalisis and their interaction with human LDL 109
Urinary glycosaminoglycan and proteoglycan excretion in normoalbuminuric patients with type 1 diabetes mellitus 109
A comparative study of the insolubilization of low density lipoproteins by two different families of aortic proteoglycans 108
Sulphated polysaccharide content and localization in some marine sponge species. 108
Plasma vitronectin is reduced in patients with myasthenia gravis: Diagnostic and pathophysiological potential 107
Proteomic analysis of plasma apolipoproteins in relation to atherosclerosis 107
Identification and characterization of biomarkers in atherosclerosis and diabetes. 106
Evaluation of plasma glycosaminoglycans levels and structure in patients undergoingcarotid endarterectomy 106
Apolipoprotein signature of hdl and ldl from atherosclerotic patients in relation with carotid plaque typology: A preliminary report 105
Hb Hamilton [beta11(A8)Val->Ile] in Sardinia. 104
Cellular adhesion of rat hepatocytes during the last phase of the phenotype differentiation 103
Significance of urinary glycosaminoglycans/proteoglycans in the evaluation of type 1 and type 2 diabetes complications 103
Marine-derived sulfated polysaccharides enhance hemocompatibility and endothelialization of nanofibrous PCL for vascular graft applications 102
Characterization of a protein-glycosaminoglycan complex in urine from healthy subjects 102
Blood and urine glycosaminoglycan variations during different hypocholesterolemic therapies in type 2 diabetic patients 101
Glycosaminoglycan and transforming growth factor beta1 changes in human plasma and urine during the menstrual cycle, in vitro fertilization treatment, and pregnancy. IF 2009: 3.970 JCR: Q1 100
Determination of galactosaminoglycan disaccharides by high performance capillary electrophoresis: applications to analysis of human aorta proteoglycans 100
Glycosamynoglycan diversity in sponge extracellular matrix 97
Hemoglobin Hamilton [β11(A8)Val→Ile] in Sardinia 97
Proteomic analysis of plasma-purified VLDL, LDL, and HDL fractions from atherosclerotic patients undergoing carotid endarterectomy: identification of Serum Amyloid A as a potential marker 97
Plasma PP13, urinary GAGs/PGs as early markers of pre-eclampsia 96
Cryopreservation of porcine aortic valve: open status of the aortic leaflets results in increased matrix glycosaminoglycan structural maintenance 95
Protein sulfhydryl-group oxidation in stable and unstable human carotid plaques 94
The role of GAGs in cell to cell adhesion of rat fibroblasts: a preliminary investigation 94
Structural analisys of plasma glycosaminoglycans in patients with atheromatous lesions 93
IDENTIFICATION, QUANTIFICATION AND STRUCTURAL CHARACTERIZATION OF GLYCOSAMINOGLYCANS FROM PORCINE AORTIC VALVE TISSUE 93
Structural and functional modifications of human aorta proteoglycans in atherosclerosis 92
Urine bikunin as a marker of renal impairment in Fabry's disease 92
Structural determinants in the C-terminal domain of apolipoprotein E mediating binding to the protein core of human aortic biglycan. IF 2000: 7.368 JCR: Q1 91
Lipoprotein(a) and the arterial wall 91
Protein oxidation in unstable plaque extracts from human carotid segments 91
GAG content and distribution in porcine aortic valve tissue and in acellular pericardium scaffolds from three mammal species 91
Chromatin microfluorometry and energy status of primary cultures of adult rat hepatocytes: Effects of testosterone and dexamethasone 91
QUANTITATIVE AND STRUCTURAL ANALYSES OF URINARY TRYPSIN INHIBITOR IN TYPE 1 AND TYPE 2 DIABETES 91
Circulating Heparan Sulfate Proteoglycans as Biomarkers in Health and Disease 91
GAG and protein composition of GAG-protein complexes from normal human plasma 90
Factors affecting S-homocysteinylation of LDL apoprotein B 90
Urinary glycosaminoglycans in patients with systemic lupus erythematosus 89
Urine Bikunin Quantitation and Structural Characterization in Type I and Type II Diabetes Patients 89
Atherosclerotic modifications of human proteoglycans 88
Urinary trypsin inhibitor is a marker of renal disease in Fabry’s patients. 88
Glycosaminoglycan content and distribution in human normal and varicose veins 86
Role of the small proteoglycan bikunin in human reproduction 86
Plasma GAG-protein complexes modify chemical and physical properties of human LDL 86
Urinary excretion of GAGs during hypocholesterolemic therapy 86
Estrogen receptors in the liver of intact and gonadectomized rats: determination by hydroxylapatite assay 85
Brain interstitial fluid and intracellular distribution of phenytoin 85
Oxidative Modifications in Advanced Atherosclerotic Plaques: A Focus on In Situ Protein Sulfhydryl Group Oxidation 85
New Capillary Zone Electrophoresis (CZE) method for glycosaminoglycan analysis 85
Evidences that atherosclerotic lesion involves modifications of arterial wall proteoglycans, affecting their interactions with LDL 85
Evaluation of low molecular mass thiols content in carotid atherosclerotic plaques 84
Modifications of low density lipoprotein induced by the interaction with heparin, chondroitin 6 sulphate and plasma high charge GAG-protein complexes 84
Preliminary investigations of LDL interactions with proteoglycans extracted from human aortic walls with different atherosclerotic lesions 84
Totale 11.366
Categoria #
all - tutte 70.904
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 70.904


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021679 0 0 0 0 0 38 176 4 200 197 43 21
2021/2022837 110 5 3 16 10 3 54 52 94 36 95 359
2022/20231.916 188 124 37 324 236 306 0 230 328 19 81 43
2023/2024594 93 41 15 16 133 102 6 32 9 12 76 59
2024/20255.069 32 40 310 56 212 122 320 881 1.955 768 263 110
2025/20264.916 276 1.731 1.126 1.000 680 103 0 0 0 0 0 0
Totale 17.478